Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

Related Citations for PubMed (Select 20379784)

1.

Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database.

Soong SJ, Ding S, Coit D, Balch CM, Gershenwald JE, Thompson JF, Gimotty P; AJCC Melanoma Task Force.

Ann Surg Oncol. 2010 Aug;17(8):2006-14. doi: 10.1245/s10434-010-1050-z. Epub 2010 Apr 9.

PMID:
20379784
2.

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM, Atkins MB, Thompson JA, Coit DG, Byrd D, Desmond R, Zhang Y, Liu PY, Lyman GH, Morabito A.

J Clin Oncol. 2001 Aug 15;19(16):3622-34.

PMID:
11504744
3.

A novel and accurate computer model of melanoma prognosis for patients staged by sentinel lymph node biopsy: comparison with the American Joint Committee on Cancer model.

Callender GG, Gershenwald JE, Egger ME, Scoggins CR, Martin RC 2nd, Schacherer CW, Edwards MJ, Urist MM, Ross MI, Stromberg AJ, McMasters KM.

J Am Coll Surg. 2012 Apr;214(4):608-17; discussion 617-9. doi: 10.1016/j.jamcollsurg.2011.12.027. Epub 2012 Feb 17.

PMID:
22342785
4.
6.

Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma.

Ben-Porat L, Panageas KS, Hanlon C, Patel A, Halpern A, Houghton AN, Coit D.

Cancer. 2006 Jan 1;106(1):163-71.

7.

Prognostic factors in 1,521 melanoma patients with distant metastases.

Barth A, Wanek LA, Morton DL.

J Am Coll Surg. 1995 Sep;181(3):193-201.

PMID:
7670677
8.

A population-based validation of the American Joint Committee on Cancer melanoma staging system.

Gimotty PA, Botbyl J, Soong SJ, Guerry D.

J Clin Oncol. 2005 Nov 1;23(31):8065-75.

9.

Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.

Schmidt H, Suciu S, Punt CJ, Gore M, Kruit W, Patel P, Lienard D, von der Maase H, Eggermont AM, Keilholz U; American Joint Committee on Cancer Stage IV Melanoma; EORTC 18951.

J Clin Oncol. 2007 Apr 20;25(12):1562-9.

10.

[Prognostic factors of localized malignant melanoma: study of 639 patients].

Nagore Enguídanos E, Oliver Martínez V, Botella Estrada R, Insa Mollá A, Fortea Baixauli JM.

Med Clin (Barc). 2005 Mar 19;124(10):361-7. Spanish.

PMID:
15766505
11.

The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up.

Francken AB, Shaw HM, Thompson JF, Soong SJ, Accortt NA, Azzola MF, Scolyer RA, Milton GW, McCarthy WH, Colman MH, McGovern VJ.

Ann Surg Oncol. 2004 Apr;11(4):426-33. Epub 2004 Mar 15.

PMID:
15070604
12.

Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.

Gimotty PA, Elder DE, Fraker DL, Botbyl J, Sellers K, Elenitsas R, Ming ME, Schuchter L, Spitz FR, Czerniecki BJ, Guerry D.

J Clin Oncol. 2007 Mar 20;25(9):1129-34.

13.

A long-term analysis of 620 patients with malignant melanoma at a major referral center.

Averbook BJ, Russo LJ, Mansour EG.

Surgery. 1998 Oct;124(4):746-55; discussion 755-6.

PMID:
9780997
14.

Survival analysis of malignant melanoma in Japan--multivariate analysis of prognostic factors.

Uehara S, Kamo R, Harada T, Ishii M.

Osaka City Med J. 2009 Jun;55(1):35-52.

PMID:
19725433
15.

Prediction of survival in patients with head and neck cancer.

Baatenburg de Jong RJ, Hermans J, Molenaar J, Briaire JJ, le Cessie S.

Head Neck. 2001 Sep;23(9):718-24.

PMID:
11505480
16.

Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients.

Rousseau DL Jr, Ross MI, Johnson MM, Prieto VG, Lee JE, Mansfield PF, Gershenwald JE.

Ann Surg Oncol. 2003 Jun;10(5):569-74.

PMID:
12794025
17.

Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center.

Azzola MF, Shaw HM, Thompson JF, Soong SJ, Scolyer RA, Watson GF, Colman MH, Zhang Y.

Cancer. 2003 Mar 15;97(6):1488-98.

18.

A single-institution validation of the AJCC staging system for stage IV melanoma.

Neuman HB, Patel A, Ishill N, Hanlon C, Brady MS, Halpern AC, Houghton A, Coit DG.

Ann Surg Oncol. 2008 Jul;15(7):2034-41. doi: 10.1245/s10434-008-9915-0. Epub 2008 May 9.

PMID:
18465172
19.

A machine learning-based approach to prognostic analysis of thoracic transplantations.

Delen D, Oztekin A, Kong ZJ.

Artif Intell Med. 2010 May;49(1):33-42. doi: 10.1016/j.artmed.2010.01.002. Epub 2010 Feb 13.

PMID:
20153956
20.

Contemporary surgical treatment of advanced-stage melanoma.

Essner R, Lee JH, Wanek LA, Itakura H, Morton DL.

Arch Surg. 2004 Sep;139(9):961-6; discussion 966-7.

PMID:
15381613
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk